Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.5%

5 terminated/withdrawn out of 198 trials

Success Rate

90.4%

+3.8% vs industry average

Late-Stage Pipeline

21%

41 trials in Phase 3/4

Results Transparency

4%

2 of 47 completed trials have results

Key Signals

50 recruiting2 with results

Enrollment Performance

Analytics

N/A
64(48.1%)
Phase 4
22(16.5%)
Phase 3
19(14.3%)
Phase 2
17(12.8%)
Early Phase 1
7(5.3%)
Phase 1
4(3.0%)
133Total
N/A(64)
Phase 4(22)
Phase 3(19)
Phase 2(17)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (198)

Showing 20 of 198 trials
NCT05965687Phase 3Completed

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

Role: collaborator

NCT06331923Not ApplicableCompleted

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients With Diabetes

Role: collaborator

NCT07272499Phase 2Recruiting

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

Role: collaborator

NCT07572903Not ApplicableRecruiting

The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease

Role: lead

NCT07672210Recruiting

PregnAncy-Related Aortic DISsEction in China

Role: collaborator

NCT07700537Not ApplicableRecruiting

Efficacy and Neural Mechanisms of Transcranial Direct Current Stimulation Targeting the Supplementary Motor Area for the Treatment of Subacute Post-stroke Aphasia

Role: lead

NCT07703267Not ApplicableNot Yet Recruiting

Non-pharmacological Interventions for People With Mild Cognitive Impairment in the Community

Role: collaborator

NCT07697391Phase 4Not Yet Recruiting

AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes

Role: lead

NCT07697547Completed

Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease

Role: collaborator

NCT07680257Early Phase 1Recruiting

An Early Clinical Study to Evaluate the Safety and Efficacy of CLDN18.2 CAR T Cell Injection in Subjects With CLDN18.2-Positive Advanced Malignant Solid Tumors

Role: collaborator

NCT07679776Enrolling By Invitation

Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus

Role: lead

NCT07657780Early Phase 1Not Yet Recruiting

CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07642427Phase 4Not Yet Recruiting

Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage

Role: collaborator

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07619027Phase 4Not Yet Recruiting

Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation

Role: collaborator

NCT07602465Not Yet Recruiting

The Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury

Role: collaborator

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT07524699Not ApplicableNot Yet Recruiting

A Study About Remote and Local Liver Surgery

Role: collaborator

NCT07589738Not ApplicableActive Not Recruiting

A Prospective, Randomized, Blind, Controlled Multicenter Clinical Study Comparing the Effectiveness of Preventive Ventricular Arrhythmia Ablation on the Prognosis After Left Ventricular Assist Device (LVAD) Surgery.

Role: lead